Karl Sune Detlof Bergström (10 January 1916 – 15 August 2004) was a Swedish biochemist whose research transformed understanding of biologically active lipids. He is best known for his role in isolating, characterizing and clarifying the biosynthetic origins of prostaglandins — a family of fatty-acid–derived signaling molecules important in inflammation, vascular tone and platelet function. For this work he shared the 1982 Nobel Prize in Physiology or Medicine.

Life and career

Bergström trained and worked in Sweden for most of his career, building a research group that combined chemistry, physiology and clinical perspectives. He held senior leadership roles at the Karolinska Institute, serving as Dean of its medical faculty and later as Rector. His administrative and academic roles helped shape medical research and training in Stockholm. For biographical summaries and archival material, see biographical resources.

Research: prostaglandins and lipid mediators

Bergström’s laboratory focused on lipid compounds derived from essential fatty acids. Through chemical isolation, structural analysis and metabolic studies, his team demonstrated how prostaglandins arise from cell membrane lipids and how they act as local hormones. This body of work clarified mechanisms behind fever, pain, blood clotting and smooth muscle activity, and it provided a biochemical framework that helped explain how common drugs modify these processes. For technical overviews of the compounds he studied, consult specialized resources.

  • Major roles: research leader, teacher and administrator at Karolinska Institute; see institutional history at Karolinska entries.
  • Scientific focus: pathways converting fatty acids to prostaglandins and related eicosanoids.
  • Collaborations: his findings were foundational for contemporaries working on platelet function and anti-inflammatory drugs, and are discussed in broader biomedical reviews (review sources).

Honors and legacy

In 1982 Bergström shared the Nobel Prize in Physiology or Medicine with Bengt I. Samuelsson and John R. Vane for discoveries concerning prostaglandins and related biologically active substances. The prize recognized both the chemical description of these mediators and their physiological significance. His work influenced cardiovascular medicine, pain management and pharmacology, shaping how researchers and clinicians approach inflammation and thrombosis. More on the Nobel recognition can be found at award summaries.

Bergström is remembered as a meticulous experimentalist and as a leader who helped bridge basic biochemistry with clinical questions. His contributions remain part of the foundational curriculum in biochemistry and pharmacology, and his studies of lipid mediators continue to inform new therapeutic approaches.